In this podcast, Thomas Keller, MD, discusses his analysis on the association of guideline-recommended chronic obstructive pulmonary disease inhaler regimens with mortality, respiratory exacerbations, and quality of life and what the findings suggest about the need to reevaluate the effectiveness of risk stratification model-based inhaled treatment strategies. More at: www.consultant360.com/pulmonology